Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
Cancer|April 15, 1993
Prognostic factors for patients with Hodgkin disease in first relapseE A Healey, N J Tarbell, L A Kalish, et al.
The New England Journal of Medicine|November 30, 1972
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapyJ C Arseneau, R W Sponzo, D L Levin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2010
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphomaJ A Barnes, A S LaCasce, K Zukotynski, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Cancer|November 15, 1992
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVDA B Kornblith, J Anderson, D F Cella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2007
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804N L Bartlett, D Niedzwiecki, J L Johnson, et al.
Blood|February 1, 1987
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrowK C Anderson, J Ritz, T Takvorian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimenM A Shipp, B Y Yeap, D P Harrington, et al.
Seminars in Hematology|April 1, 1987
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphomaG P Canellos, A T Skarin, M M Klatt, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
Cancer|April 15, 1993
Prognostic factors for patients with Hodgkin disease in first relapseE A Healey, N J Tarbell, L A Kalish, et al.
The New England Journal of Medicine|November 30, 1972
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapyJ C Arseneau, R W Sponzo, D L Levin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2010
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphomaJ A Barnes, A S LaCasce, K Zukotynski, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Cancer|November 15, 1992
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVDA B Kornblith, J Anderson, D F Cella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2007
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804N L Bartlett, D Niedzwiecki, J L Johnson, et al.
Blood|February 1, 1987
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrowK C Anderson, J Ritz, T Takvorian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimenM A Shipp, B Y Yeap, D P Harrington, et al.
Seminars in Hematology|April 1, 1987
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphomaG P Canellos, A T Skarin, M M Klatt, et al.
Pageof 32